Chronic Disease: Clinical Trials

18,761 trials for Chronic Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10721 completed, 2669 unknown, 1735 recruiting, 1416 terminated. 5453 Not applicable, 3685 Phase 2, 2445 Phase 1, 1956 Phase 3, 1485 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable5453Completed 2985, Unknown 914, Recruiting 563, Not yet recruiting 300, Terminated 300, Active not recruiting 200, Withdrawn 131, Enrolling by invitation 44, Suspended 16
Phase 23685Completed 2193, Terminated 463, Unknown 299, Recruiting 286, Active not recruiting 181, Withdrawn 150, Not yet recruiting 88, Enrolling by invitation 15, Suspended 10
Phase 12445Completed 1495, Terminated 324, Recruiting 188, Unknown 158, Active not recruiting 115, Withdrawn 98, Not yet recruiting 50, Suspended 9, Enrolling by invitation 8
Phase 31956Completed 1301, Unknown 180, Terminated 178, Recruiting 121, Active not recruiting 74, Withdrawn 54, Not yet recruiting 37, Enrolling by invitation 7, Suspended 4
Phase 41485Completed 880, Unknown 288, Terminated 103, Recruiting 73, Withdrawn 65, Not yet recruiting 37, Active not recruiting 33, Enrolling by invitation 4, Suspended 2
Early Phase 1149Completed 59, Unknown 25, Recruiting 24, Terminated 15, Withdrawn 9, Not yet recruiting 8, Active not recruiting 6, Enrolling by invitation 2, Suspended 1

Follow Chronic Disease: new trials by email Literature Review of Chronic Disease trials Research Report on Chronic Disease

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MRI Technical Development and Applications in Kidney Disease
Chronic Kidney Diseases, Kidney Transplantation
Not yet recruitingUniversity of Minnesota1802028-06-302026-04-13
Safety and Outcomes of MUSE Stem Cell Therapy in Individuals With Traumatic Brain Injury
MUSE Stem Cell Therapy - Traumatic Brain Injury, Traumatic Brain Injury (TBI) Patients
Not yet recruitingHealing Hope International102028-01-012026-03-10
Veteran Centered Meal Intervention in Chronic Kidney Disease
Medically tailored meals (MTMs) - Chronic Kidney Disease
Not applicableNot yet recruitingVA Office of Research and Development1002027-10-012026-09-03
Technology-enabled Social Network Intervention to Increase Live Donor Kidney Transplantation
Digital education outreach intervention for kidney transplant access and human guide, Digital education outreach intervention for kidney transplant access only (unguided) - End-Stage Renal Disease, Chronic Kidney Diseases
Not applicableNot yet recruitingState University of New York at Buffalo5502027-10-012026-10-20
Developing an Intervention to Optimize Virtual Care Adoption for COPD Management
VC-OPTIONS - Chronic Obstructive Pulmonary Disease
Not applicableNot yet recruitingVA Office of Research and Development402027-09-022026-09-29
Intermittent Fasting for Pancreatitis
Intermittent Fasting, No intermittent fasting - Pancreatitis, Pancreatitis, Acute
Not applicableNot yet recruitingH. Lee Moffitt Cancer Center and Research Institute642027-09-012026-09-17
Anti-Interleukin-6 (IL6) in Calciphylaxis
Tocilizumab - Calciphylaxis
Phase 1Not yet recruitingBoston Medical Center102027-09-012026-07-16
Zanubrutinib and Sonrotoclax for the Treatment of Relapsed Chronic Lymphocytic Leukemia /Small Lymphocytic Leukemia, ZeuS-2 Trial
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Phase 2Not yet recruitingCity of Hope Medical Center442027-08-042026-09-10
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
Remote Management, Remote Monitoring Only - COPD (Chronic Obstructive Pulmonary Disease), Acute Exacerbation of COPD
Not applicableNot yet recruitingSir Run Run Shaw Hospital2362027-08-012026-08-06
Adaptive Cell Phone Support (ACPS)
Adaptive Cell Phone Support, Computer-Delivered Cell Phone Support, Automated Text Reminders - Medication Adherence
Not applicableNot yet recruitingChildren's Hospital Los Angeles962027-08-012025-07-30
VR Pilot for Pancreatitis
Gut Directed VR, Sham Control VR - Chronic Pancreatitis, Recurrent Pancreatitis
Not applicableNot yet recruitingCedars-Sinai Medical Center202027-07-222026-08-05
Trial Without Borders IMPLEMENT-CKD: IMPLEMENTation of Evidence-Based SGLT2i to Reduce Global Burden of Cardiovascular and Chronic Kidney Disease
Implementation of recommendations - Implementation Research, Kidney Disease
Not yet recruitingThe University of Queensland13902027-07-012026-10-02
Lentiviral Gene Therapy for CGD
Infusion of lentiviral TYF-CGD-modified autologous stem cells - Chronic Granulomatous Disease
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute102027-07-012026-08-26
RSV Vaccination to Reduce Recurrent AECOPD
RSV vaccination (Arexvy, GlaxoSmithKline) - COPD, RSV
Phase 4Not yet recruitingChinese University of Hong Kong3202027-07-012026-04-13
cfMSC Stem Cell Therapy Targeting COPD
clonal fetal MSCs - Chronic Obstructive Pulmonary Disease (COPD)
Phase 1 / Phase 2Not yet recruitingShenzhen Geno-Immune Medical Institute302027-06-302026-08-27
Kidney RISE: Randomized Integrated Supportive CarE Trial
Kidney RISE - Chronic Kidney Disease (Stages 4 and 5)
Not applicableNot yet recruitingNYU Langone Health2802027-05-012026-08-03
Breakthrough - T1DM and Chronic Kidney Disease
Tegoprubart, Islet Cell Transplant - Diabete Type 1, Chronic Kidney Disease
Phase 1 / Phase 2RecruitingUniversity of Chicago102027-04-292026-08-20
PATH-03 Paraguay Feasibility Study
ePATH System will be used to create an endoAVF - Kidney Disease, End-Stage
Not applicableNot yet recruitingPathfinder Medical202027-03-012026-09-17
A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS
Remibrutinib (Open Label) - Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Secondary Progressive
Phase 2Not yet recruitingMoein Amin202027-03-012026-08-19
C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Progressive Multiple Sclerosis Refractory to Standard Therapy
C-CAR168 - Multiple Sclerosis, Primary Progressive Multiple Sclerosis
Phase 1 / Phase 2Not yet recruitingAbelZeta Inc.1192027-02-012026-10-13

Showing 20 of 18761. Sign in to see all of them.

Narrower conditions

Pulmonary Disease, Chronic Obstructive (5327)  ·  Renal Insufficiency, Chronic (3071)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2018)  ·  Kidney Failure, Chronic (1997)  ·  Hepatitis C, Chronic (907)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (905)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (876)  ·  Hepatitis B, Chronic (860)  ·  Leukemia (842)  ·  Lymphoma, Non-Hodgkin (819)  ·  Leukemia, Myeloid, Acute (811)  ·  Lymphoma, Follicular (721)  ·  Myelodysplastic Syndromes (691)  ·  Lymphoma, Mantle-Cell (679)

Broader conditions

Pathological Conditions, Signs and Symptoms (18759)  ·  Disease Attributes (18758)  ·  Pathologic Processes (18745)  ·  Respiratory Tract Diseases (6251)  ·  Lung Diseases (6036)  ·  Lung Diseases, Obstructive (5387)  ·  Urogenital Diseases (5040)  ·  Female Urogenital Diseases and Pregnancy Complications (4956)  ·  Female Urogenital Diseases (4947)  ·  Male Urogenital Diseases (4944)  ·  Urologic Diseases (4883)  ·  Kidney Diseases (4606)  ·  Renal Insufficiency (4462)  ·  Immune System Diseases (3950)

Interventions

Ribavirin (416)  ·  Cyclophosphamide (408)  ·  Rituximab (357)  ·  peginterferon alfa-2a (308)  ·  fludarabine phosphate (304)  ·  Tiotropium Bromide (242)  ·  fludarabine (206)  ·  Exercise (183)  ·  Mycophenolic Acid (182)  ·  Peripheral Blood Stem Cell Transplantation (179)  ·  Imatinib Mesylate (169)  ·  Tacrolimus (161)  ·  Cyclosporine (153)  ·  Busulfan (150)  ·  venetoclax (147)

Sponsors

GlaxoSmithKline (339)  ·  AstraZeneca (311)  ·  Novartis Pharmaceuticals (293)  ·  Boehringer Ingelheim (272)  ·  M.D. Anderson Cancer Center (241)  ·  National Cancer Institute (NCI) (211)  ·  Hoffmann-La Roche (196)  ·  Merck Sharp & Dohme LLC (154)  ·  Fred Hutchinson Cancer Center (133)  ·  Assiut University (125)  ·  Mayo Clinic (115)  ·  AbbVie (111)  ·  Gilead Sciences (109)  ·  VA Office of Research and Development (98)  ·  Bristol-Myers Squibb (89)

Countries

United States (6682)  ·  Germany (1516)  ·  China (1510)  ·  France (1478)  ·  United Kingdom (1437)  ·  Canada (1290)  ·  Spain (1108)  ·  Italy (1062)  ·  South Korea (686)  ·  Poland (660)  ·  Netherlands (639)  ·  Belgium (635)  ·  Australia (624)  ·  Taiwan (605)  ·  Turkey (Türkiye) (597)

Results publications

PMID 40576086, PMID 36005278, PMID 33511633, PMID 35018639, PMID 36791280, PMID 32499241, PMID 35224730, PMID 37916745, PMID 30739368, PMID 34515338, PMID 33586138, PMID 34495549, PMID 37870148, PMID 32390133, PMID 32943047, PMID 38189593, PMID 30977945, PMID 34398557, PMID 35815359, PMID 30012435, PMID 30923816, PMID 33283264, PMID 34164803, PMID 36472416, PMID 37542951, PMID 37651553, PMID 42149813, PMID 31568620, PMID 32588430, PMID 33782940, PMID 30529905, PMID 35235189, PMID 38018702, PMID 38620092, PMID 38770818, PMID 42551404, PMID 17507545, PMID 23524640, PMID 23620574, PMID 28427875, PMID 28835440, PMID 29377566, PMID 30885996, PMID 33107592, PMID 35514131, PMID 39423760, PMID 39963952, PMID 10377201, PMID 12091180, PMID 19720809

NIH funding

2023 (99), 2015 (84), 2009 (69), 2014 (68), 2025 (59), 2017 (57), P30CA015704 (56), 2016 (54), 2019 (54), 2018 (53), 2008 (41), P30CA006973 (33), P30CA033572 (33), P30CA015083 (31), 2005 (28)